Colorectal Cancer Therapeutics Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4141254
- 111 Pages
- December 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Colorectal Cancer Therapeutics market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Colorectal Cancer Therapeutics market segmented into
Diagnostics
Therapeutics
Based on the end-use, the global Colorectal Cancer Therapeutics market classified into
Hospitals
Clinic
Research institutions
Based on geography, the global Colorectal Cancer Therapeutics market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Taiho Pharma
Merck KGaA
Amgen
Takeda
Roche
Eli Lilly
Sanofi
Regeneron
Bayer
Onyx
Bristol-Myers Squib
Sumitomo Dainippon Pharma
Array BioPharma
Hutchison MediPharma
Jiangsu Hengrui Medicine
Jiangsu Chia-Tai Tianqing
Suzhou Zelgen Biopharmaceuticals
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL COLORECTAL CANCER THERAPEUTICS INDUSTRY
2.1 Summary about Colorectal Cancer Therapeutics Industry
2.2 Colorectal Cancer Therapeutics Market Trends
2.2.1 Colorectal Cancer Therapeutics Production & Consumption Trends
2.2.2 Colorectal Cancer Therapeutics Demand Structure Trends
2.3 Colorectal Cancer Therapeutics Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Diagnostics
4.2.2 Therapeutics
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Clinic
4.3.3 Research institutions
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Diagnostics
5.2.2 Therapeutics
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Clinic
5.3.3 Research institutions
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Diagnostics
6.2.2 Therapeutics
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Clinic
6.3.3 Research institutions
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Diagnostics
7.2.2 Therapeutics
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Clinic
7.3.3 Research institutions
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Diagnostics
8.2.2 Therapeutics
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Clinic
8.3.3 Research institutions
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Diagnostics
9.2.2 Therapeutics
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Clinic
9.3.3 Research institutions
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Taiho Pharma
10.1.2 Merck KGaA
10.1.3 Amgen
10.1.4 Takeda
10.1.5 Roche
10.1.6 Eli Lilly
10.1.7 Sanofi
10.1.8 Regeneron
10.1.9 Bayer
10.1.10 Onyx
10.1.11 Bristol-Myers Squib
10.1.12 Sumitomo Dainippon Pharma
10.1.13 Array BioPharma
10.1.14 Hutchison MediPharma
10.1.15 Jiangsu Hengrui Medicine
10.1.16 Jiangsu Chia-Tai Tianqing
10.1.17 Suzhou Zelgen Biopharmaceuticals
10.2 Colorectal Cancer Therapeutics Sales Date of Major Players (2017-2020e)
10.2.1 Taiho Pharma
10.2.2 Merck KGaA
10.2.3 Amgen
10.2.4 Takeda
10.2.5 Roche
10.2.6 Eli Lilly
10.2.7 Sanofi
10.2.8 Regeneron
10.2.9 Bayer
10.2.10 Onyx
10.2.11 Bristol-Myers Squib
10.2.12 Sumitomo Dainippon Pharma
10.2.13 Array BioPharma
10.2.14 Hutchison MediPharma
10.2.15 Jiangsu Hengrui Medicine
10.2.16 Jiangsu Chia-Tai Tianqing
10.2.17 Suzhou Zelgen Biopharmaceuticals
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
Table Colorectal Cancer Therapeutics Product Type Overview
Table Colorectal Cancer Therapeutics Product Type Market Share List
Table Colorectal Cancer Therapeutics Product Type of Major Players
Table Brief Introduction of Taiho Pharma
Table Brief Introduction of Merck KGaA
Table Brief Introduction of Amgen
Table Brief Introduction of Takeda
Table Brief Introduction of Roche
Table Brief Introduction of Eli Lilly
Table Brief Introduction of Sanofi
Table Brief Introduction of Regeneron
Table Brief Introduction of Bayer
Table Brief Introduction of Onyx
Table Brief Introduction of Bristol-Myers Squib
Table Brief Introduction of Sumitomo Dainippon Pharma
Table Brief Introduction of Array BioPharma
Table Brief Introduction of Hutchison MediPharma
Table Brief Introduction of Jiangsu Hengrui Medicine
Table Brief Introduction of Jiangsu Chia-Tai Tianqing
Table Brief Introduction of Suzhou Zelgen Biopharmaceuticals
Table Products & Services of Taiho Pharma
Table Products & Services of Merck KGaA
Table Products & Services of Amgen
Table Products & Services of Takeda
Table Products & Services of Roche
Table Products & Services of Eli Lilly
Table Products & Services of Sanofi
Table Products & Services of Regeneron
Table Products & Services of Bayer
Table Products & Services of Onyx
Table Products & Services of Bristol-Myers Squib
Table Products & Services of Sumitomo Dainippon Pharma
Table Products & Services of Array BioPharma
Table Products & Services of Hutchison MediPharma
Table Products & Services of Jiangsu Hengrui Medicine
Table Products & Services of Jiangsu Chia-Tai Tianqing
Table Products & Services of Suzhou Zelgen Biopharmaceuticals
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Colorectal Cancer Therapeutics Market Forecast (Million USD) by Region 2021f-2026f
Table Global Colorectal Cancer Therapeutics Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Colorectal Cancer Therapeutics Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Colorectal Cancer Therapeutics Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
